OPKO Health Inc (OPK) Q3 2024 Earnings Call Highlights: A Turnaround in Profitability Amidst ... [Yahoo! Finance]
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: Yahoo! Finance
Diagnostic Segment Revenue: $121.3 million for Q3 2024, down from $131.7 million in Q3 2023. Pharmaceutical Segment Revenue: $52.4 million for Q3 2024, up from $46.9 million in Q3 2023. Net Income: $24.9 million or 3 per diluted share for Q3 2024, compared to a net loss of $84.5 million or 11 per share in Q3 2023. Operating Income: $58.5 million for Q3 2024, compared to an operating loss of $29.1 million in Q3 2023. Gain on Labcorp Transaction: $121.5 million recorded in Q3 2024. R&D Expenses: $28.2 million for Q3 2024, up from $18.9 million in Q3 2023. Non-recurring Costs: Approximately $30 million in Q3 2024 for severance, facility closure costs, and contractual volume shortfalls. Fourth Quarter Revenue Guidance: Total revenues between $155 and $160 million. Warning! GuruFocus has detected 6 Warning Signs with OPK. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript OPKO Health Inc
Show less
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswire
- GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover [Yahoo! Finance]Yahoo! Finance
- Eileen Fisher zeroes in on the millennials and Gen Z shoppers who love ‘slow fashion' and ‘quiet luxury' [Fortune]Fortune
- GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary [Yahoo! Finance]Yahoo! Finance
- Phillip Frost Buys Handful Of Shares In OPKO Health [Yahoo! Finance]Yahoo! Finance
OPK
Earnings
- 11/7/24 - Beat
OPK
Sec Filings
- 11/22/24 - Form 4
- 11/20/24 - Form 4/A
- 11/15/24 - Form SC
- OPK's page on the SEC website